You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PAXIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Paxil patents expire, and what generic alternatives are available?

Paxil is a drug marketed by Apotex and is included in four NDAs.

The generic ingredient in PAXIL is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Paxil

A generic version of PAXIL was approved as paroxetine hydrochloride by APOTEX on July 30th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PAXIL?
  • What are the global sales for PAXIL?
  • What is Average Wholesale Price for PAXIL?
Drug patent expirations by year for PAXIL
Drug Prices for PAXIL

See drug prices for PAXIL

Drug Sales Revenue Trends for PAXIL

See drug sales revenues for PAXIL

Pharmacology for PAXIL

US Patents and Regulatory Information for PAXIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-001 Oct 9, 1998 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-002 Dec 29, 1992 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-004 Oct 9, 1998 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex PAXIL CR paroxetine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020936-002 Feb 16, 1999 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PAXIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-001 Dec 29, 1992 ⤷  Sign Up ⤷  Sign Up
Apotex PAXIL paroxetine hydrochloride SUSPENSION;ORAL 020710-001 Jun 25, 1997 ⤷  Sign Up ⤷  Sign Up
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-004 Dec 29, 1992 ⤷  Sign Up ⤷  Sign Up
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-001 Dec 29, 1992 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PAXIL

See the table below for patents covering PAXIL around the world.

Country Patent Number Title Estimated Expiration
Belgium 1011664 ⤷  Sign Up
Morocco 23802 ⤷  Sign Up
Canada 2274389 COMPRIMES DE PAROXETINE ET PROCEDE DE PREPARATION (PAROXETINE TABLETS AND PROCESS TO PREPARE THEM) ⤷  Sign Up
Slovenia 21923 Paroksetin hidroklorid anhidrat brez vezanega organskega topila (PAROXETINE HYDROCHLORIDE ANHYDRATE FREE OF BOUND ORGANIC SOLVENT) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.